MA

Marc G. Achen

VL Vegenics Limited: 9 patents #2 of 18Top 15%
LR Ludwig Institute For Cancer Research: 8 patents #78 of 611Top 15%
VL Vegenics Pty Limited: 5 patents #2 of 30Top 7%
HL Helsinki University Licensing: 3 patents #5 of 45Top 15%
LL Licentia Group Limited: 1 patents #14 of 76Top 20%
Overall (All Time): #174,775 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
8759286 Pharmaceutical compositions comprising a VEGF-D polypeptide Stephen A. Stacker, Kari Alitalo, Andrew Frederick Wilks 2014-06-24
8461109 Method of enhancing the acceptance and/or healing of a skin graft Steven Stacker, Kari Alitalo 2013-06-11
8455453 Use of VEGF-D gene to prevent restenosis Kari Alitalo, Seppo Yla-Herttuala, Mikko O. Hiltunen, Markku M. Jeltsch 2013-06-04
8445234 Methods of making VEGF-D polypeptides Stephen A. Stacker, Kari Alitalo, Andrew Frederick Wilks 2013-05-21
8227410 Methods of stimulating wound healing by administration of vascular endothelial growth factor D (VEGF-D) Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2012-07-24
7947472 Expression vectors and cell lines expressing vascular endothelial growth factor D Steven Stacker, Kari Alitalo 2011-05-24
7928061 Methods of using VEGF-D polypeptides Steven Stacker, Kari Alitalo, Andrew Frederick Wilks 2011-04-19
7887800 Methods for inhibiting VEGF-D Bradley McColl, Megan E. Baldwin, Stephen A. Stacker 2011-02-15
7871798 Mammalian cells that express VEGF-D polypeptides Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2011-01-18
7846437 Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same Steven Stacker, Christoph Renner 2010-12-07
7785803 Antibody diagnostic kits and methods of use Steven Stacker, Kari Alitalo, Andrew Frederick Wilks 2010-08-31
7662932 Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use Andrew Frederick Wilks, Stephen A. Stacker, Kari Alitalo 2010-02-16
7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue Steven Stacker 2009-05-19
7479270 Methods and compositions for activating VEGF-D and VEGF-C Bradley McColl, Megan E. Baldwin, Steven Stacker 2009-01-20
7410639 Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2008-08-12
7122654 Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2006-10-17
7097986 Antibodies to truncated VEGF-D and uses thereof Steven Stacker 2006-08-29
7045133 VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor Richard Hughes, Steven Stacker, Angela Cendron 2006-05-16
6958147 Use of VEGF-C to prevent restenosis Kari Alitalo, Seppo Yla-Herttuala, Mikko O. Hiltunen, Markku M. Jeltsch 2005-10-25
6730489 Antibodies to truncated VEGF-D and uses thereof Steven Stacker 2004-05-04
6689352 Method for activating only the vascular endothelial growth factor receptor-3 and uses thereof Steven Stacker 2004-02-10
6689580 Growth factor Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2004-02-10
6383484 Antibodies to truncated VEGF-D and thereof Steven Stacker 2002-05-07
6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides Andrew Frederick Wilks, Steven Stacker, Kari Alitalo 2001-05-22